23 Myalgic Encephalomyelitis Clinical Trials in Dallas, TX (2026)

Q: How do I join a clinical trial in Dallas?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Dallas research site will contact you.

Recruiting Myalgic Encephalomyelitis Studies in Dallas

NCT07032389Recruiting

A Polypill for Acute Coronary Syndrome

The current study aims to investigate whether combining the standard medications prescribed after acute coronary syndrome (ACS)-aspirin, P2Y12 inhibitors, and statins-into a single polypill can improv...

Dallas, TX1,000 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT06233799Recruiting

Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder

The primary objective of this study is to evaluate the efficacy of extended release naltrexone plus bupropion XL (XR-NTX/BUP-XL) compared to matched injectable and oral placebo (iPLB/oPLB) in reducing...

Dallas, TX360 participantsNational Institute on Drug Abuse (NIDA)

View Study Details

NCT06292104Recruiting

Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS)

This is an observational study to deeply phenotype the disorder of POTS using multiple testing modalities....

Dallas, TX350 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT07335497Recruiting

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

The purpose of this study is to determine the safety and tolerability of monotherapy CR-001 and identify the maximum tolerated dose (MTD), and/or optimal biologic dose and Recommended Phase 2 Dose(s) ...

Dallas, TX290 participantsCrescent Biopharma, Inc.

View Study Details

NCT06234397Recruiting

Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors

This is a First-in-Human, Phase 1, Dose-Escalation and Dose-Expansion study of BH3120, as a single agent and in combination with pembrolizumab, to assess safety, tolerability, MTD, RP2D, PK, and effic...

Dallas, TX245 participantsHanmi Pharmaceutical Company Limited

View Study Details

NCT06859788Recruiting

SPI-1005 for the Treatment of Meniere's Disease (Open Label)

Study of the safety of open-label SPI-1005 400 mg BID treatment in adults with Meniere's Disease (MD) for 6 or 12 months to support chronic or chronic intermittent use....

Dallas, TX200 participantsSound Pharmaceuticals, Incorporated

View Study Details

NCT06781983Recruiting

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

This is a first-in-human, open-label, multicenter, Phase 1 study to evaluate the safety, tolerability and preliminary efficacy of IPH4502 and to determine the recommended Phase 2 dose (RP2D) in advanc...

Dallas, TX145 participantsInnate Pharma

View Study Details

NCT06496750Recruiting

Ketamine for Methamphetamine Use Disorder

This study aims to determine whether treatment response with IV ketamine is superior to treatment response with IV midazolam in adults with moderate to severe MUD. The study design is a 12-week rando...

Dallas, TX120 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT02323399Recruiting

Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IV

The primary objective of this study is to evaluate the dose effect of Phenylephrine Hydrochloride Injection on the treatment of clinically relevant decreased blood pressure in the pediatric population...

Dallas, TX100 participantsWest-Ward Pharmaceutical

View Study Details

NCT03340506Recruiting

Dabrafenib and/or Trametinib Rollover Study

This study is to provide access for patients who are receiving treatment with dabrafenib and/or trametinib in a Novartis-sponsored Oncology Global Development, Global Medical Affairs or a former GSK-s...

Dallas, TX100 participantsNovartis Pharmaceuticals

View Study Details

NCT05693701Recruiting

Multicomponent Intervention Study- Blood Donors With High Cholesterol

The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia)....

Dallas, TX100 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT07426016Recruiting

Video vs. Direct Laryngoscopy for Less Invasive Surfactant Administration

Many preterm babies born between 22-28+6 weeks' estimated gestational age (EGA) need surfactant, a medicine that helps the lungs. The goal of the study is to compare the use of video-based visualizati...

Dallas, TX100 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT07211685Recruiting

A Study to Learn About How Well BAY 3401016 Works in Adults With Alport Syndrome

Alport syndrome (AS) is a rare genetic condition that causes kidney disease, hearing loss, and eye abnormalities that occur due to changes in specific genes (COL4A3, COL4A4, and COL4A5). These genes h...

Dallas, TX60 participantsBayer

View Study Details

NCT07157254Recruiting

A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)

The main goal of the study is to evaluate the safety and efficacy of GTX-102 in participants with Angelman syndrome....

Dallas, TX60 participantsUltragenyx Pharmaceutical Inc

View Study Details

NCT06789445Recruiting

A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

Study OpCT-001-101 is a Phase 1/2a first-in-human, multisite, 2-part interventional study to evaluate the safety, tolerability, and the effect on clinical outcomes of OpCT-001 in up to approximately 5...

Dallas, TX54 participantsBlueRock Therapeutics

View Study Details

NCT06465953Recruiting

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

This study will enroll participants with myelodysplastic syndromes (MDS) with an Isocitrate dehydrogenase protein, 1 (IDH1) mutation, who have not received treatment with a hypomethylating agent previ...

Dallas, TX48 participantsInstitut de Recherches Internationales Servier

View Study Details

NCT07288112Recruiting

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

The goal of this clinical trial is to learn if DOC1021 + pIFN will be safe and will lead to tumor responses in patients with refractory melanoma. DOC1021 is a dendritic cell immunotherapy derived from...

Dallas, TX35 participantsDiakonos Oncology Corporation

View Study Details

NCT05691465Recruiting

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

This phase II trial studies how well lutetium Lu 177 dotatate works in treating patients with prostate cancer with neuroendocrine differentiation that has spread to other places in the body (metastati...

Dallas, TX35 participantsNational Cancer Institute (NCI)

View Study Details

NCT03849963Recruiting

Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain

Investigators propose to develop hyperpolarized \[13C\]-labeled pyruvate as potential imaging probes to assess two essential in vivo processes in cerebral metabolism: oxidative metabolism and synthesi...

Dallas, TX28 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT05665244Recruiting

Laryngeal Cryotherapy for Refractory Neurogenic Cough

This study aims to evaluate the safety and efficacy of upper aerodigestive tract cryotherapy treatment in patients with refractory neurogenic cough in a prospective pilot study with a validated patien...

Dallas, TX28 participantsUniversity of Texas Southwestern Medical Center

View Study Details

NCT06439836Recruiting

Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy

This phase I trial tests the safety, side effects, best dose, and effectiveness of emavusertib (CA-4948) in combination with pembrolizumab in treating patients with urothelial cancer that has spread f...

Dallas, TX27 participantsNational Cancer Institute (NCI)

View Study Details

NCT07105254Recruiting

An Open-label Single Center, Proof of Concept Study Evaluating the Efficacy of Roflumilast Foam 0.3% in Pediatric Patients With Non-Segmental Vitiligo (NSV)

An open-label single center, proof of concept study evaluating the efficacy of Roflumilast foam 0.3% in pediatric subjects with Non-Segmental Vitiligo (NSV)...

Dallas, TX20 participantsDerm Texas, PLLC

View Study Details

NCT06118515Recruiting

A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus

This is a Phase 1 single-arm open-label study of letermovir in neonates with symptomatic congenital Cytomegalovirus (CMV) disease. There will be two groups enrolled. Group 1 will be comprised of 4 sub...

Dallas, TX12 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

About Myalgic Encephalomyelitis Clinical Trials in Dallas

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 23 myalgic encephalomyelitis clinical trials recruiting participants in Dallas, TX. These studies are seeking a combined 3,517 participants. Research is being sponsored by University of Texas Southwestern Medical Center, National Institute on Drug Abuse (NIDA), Crescent Biopharma, Inc. and 13 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Dallas — FAQ

Are there myalgic encephalomyelitis clinical trials in Dallas?

Yes, there are 23 myalgic encephalomyelitis clinical trials currently recruiting in Dallas, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Dallas?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Dallas research site will contact you about next steps.

Are clinical trials in Dallas free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Dallas studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 23 active trials in Dallas are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 13, 2026 from ClinicalTrials.gov